(IUPAC) nameN-[4-cyano-3-(trifluoromethyl)phenyl]- casodex astzen hydroxy-2-methyl- propanamideIdentifiersCAS number 90357-06-5ATC code L02BB03PubChem 56069DrugBank APRD00042Chemical dataFormula C18H14F4N2O4SMol. mass 430.374 g/molPharmacokinetic dataBioavailability.

who has shown a hypersensitivity casodex astzen casodex astzen its use.[edit] Adverse reactionsAdverse reactions include reproductive system and breast disorders, breast tenderness, gynaecomastia, hot flushes, gastrointestinal disorders, diarrhoea, nausea, hepatic changes (elevated levels of transaminases, jaundice), asthenia and pruritus.[edit] casodex astzen linksCasodex, Cosudex (manufacturer's website)Bicalutamide (patient information)[hide]v • d • eSex hormones and casodex astzen agents (primarily G03, also L02, H01C) - human endogenous in CAPSProgestogens:(receptor) PROGESTERONE,Dienogest, Desogestrel, Drospirenone, Dydrogesterone, Ethisterone, Etonogestrel, Ethynodiol diacetate, Gestodene, Gestonorone, Levonorgestrel, casodex astzen Medroxyprogesterone, Megestrol, Norelgestromin, Norethisterone, Norethynodrel, Norgestimate, Norgestrel, Norgestrienone, TiboloneSelective progesterone receptor modulator: Bazedoxifene, Clomifene, Fulvestrant, Lasofoxifene, Raloxifene, Tamoxifen, ToremifeneAromatase inhibitor: Aminogluthetimide, Anastrozole.

hepaticHalf life 5.8 daysExcretion ?Therapeutic considerationsPregnancy cat. X(US)Legal status ? Prescription.